Dr. Olga Bezzubova has nearly 20 years of experience in obtaining and defending intellectual property rights for clients in the fields of pharmaceuticals, biotechnology, and diagnostics. She advises on all aspects of patent prosecution and opposition, patent validity, and infringement. Olga's training in physics and biology allows her to counsel clients in matters involving various aspects of cell biology, genomics, proteomics, molecular biology, food science, biopharmaceuticals, and biophysics, as well as emerging technologies at the convergence of biological and physical sciences.
Olga received her Ph.D. at the Basel Institute of Immunology (BII) in Switzerland with a focus on immunoglobulin gene rearrangements. This unique experience allows her a particular insight into matters relating to immunology with focus on antibodies and similar areas. Olga has represented clients in highly competitive areas of RNA interference (RNAi) and CRISPR/Cas.
Olga's practice also includes performing patent invalidity, noninfringement and freedom-to-operate analyses, and conducting patent portfolio for clients, including potential investors, acquirers, and licensees. She also has experience in providing strategic advice and managing worldwide patent portfolios of established biotech companies as well as start-ups. Close work with her U.S. colleagues provides Olga with insight into USPTO patent prosecution and inter partes review (IPR) proceedings.
Olga has authored and coauthored numerous publications in the field of molecular genetics and IP. She also has taught IP classes at the Institute for Machine Tools and Business Sciences (IWB) at the Technical University in Munich.
- February 7, 2017
Brexit and the Unitary Patent System, JD Women in IP
- November 19, 2013
IP Strategies for Life Science Companies: The New European System, Seminar for France Biotech
- June 4, 2013
Divisionals in Europe: Practical Advice
- March 25, 2013
Europe's New Unitary Patent and Unified Patent Court: How the introduction of the Unitary Patent and Unified Patent Court will impact your existing patent portfolio
- European Qualification Exam (2002); German Patent Bar Exam (2001); Swiss Federal Institute of Technology Zurich, Switzerland (Master of Advanced Studies in IP 1997); University of Basel, Switzerland (Ph.D. in Molecular Biology 1996); Moscow State University, Russia (Diploma in Physics 1993)
- European Patent Office (EPO); German Patent and Trademark Office (GPTO); German Federal Patent Court (BPatG); German Federal Supreme Court (BGH) in nullity appeal proceedings; German Federal Office for Plant Varieties (BSA); International Bureau of WIPO (IB)
- English, German, and Russian